Back to Search
HARRIET WIEDER, MD
MD
Developmental - Behavioral Pediatrics Physician
NPI: 1518014349Individual
Specialties, Licenses & Credentials
Pediatrics Physician
Pediatrics
Code: 208000000X
162962(NY)
Developmental - Behavioral Pediatrics PhysicianPrimary
Pediatrics — Developmental - Behavioral Pediatrics
Code: 2080P0006X
56400(CT)162962(NY)
Research & Publications (20)
PET/CT with Gluc-Lys-([(18)F]FP)-TOCA: correlation between uptake, size and arterial perfusion in somatostatin receptor positive lesions.
PMID 17912524·Eur J Nucl Med Mol Imaging·2008
8-other
Prediction of tumor response by FDG-PET: comparison of the accuracy of single and sequential studies in patients with adenocarcinomas of the esophagogastric junction.
PMID 17680242·Eur J Nucl Med Mol Imaging·2007
4-observational
Rectal cancer: MR imaging before neoadjuvant chemotherapy and radiation therapy for prediction of tumor-free circumferential resection margins and long-term survival.
PMID 17463134·Radiology·2007
3-trial
PET imaging with [18F]3'-deoxy-3'-fluorothymidine for prediction of response to neoadjuvant treatment in patients with rectal cancer.
PMID 17195074·Eur J Nucl Med Mol Imaging·2007
8-other
[Radiological diagnostics for iatrogenic retained foreign bodies after surgery].
PMID 17151841·Chirurg·2007
8-other
Comparison of changes in tumor metabolic activity and tumor size during chemotherapy of adenocarcinomas of the esophagogastric junction.
PMID 16330567·J Nucl Med·2005
4-observational
Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment.
PMID 14990646·J Clin Oncol·2004
4-observational
PET imaging with [11C]methyl- L-methionine for therapy monitoring in patients with rectal cancer.
PMID 12029553·Eur J Nucl Med Mol Imaging·2002
3-trial
18F-FDG PET and 18F-FDG PET/CT for assessing response to therapy in esophageal cancer.
PMID 19380406·J Nucl Med·2009
6-review
Evaluation of dual-phase multi-detector-row CT for detection of intestinal bleeding using an experimental bowel model.
PMID 19018538·Eur Radiol·2009
7-preclinical
Prediction of tumour response by FDG-PET in patients with adenocarcinomas of the oesophagogastric junction.
PMID 18985342·Eur J Nucl Med Mol Imaging·2009
8-other
Electrically detected displacement assay (EDDA): a practical approach to nucleic acid testing in clinical or medical diagnosis.
PMID 18425643·Anal Bioanal Chem·2008
8-other
Early metabolic response evaluation by fluorine-18 fluorodeoxyglucose positron emission tomography allows in vivo testing of chemosensitivity in gastric cancer: long-term results of a prospective study.
PMID 18381939·Clin Cancer Res·2008
8-other
Visualisation of metastatic oesophageal and gastric cancer and prediction of clinical response to palliative chemotherapy using 18FDG PET.
PMID 18084682·Nuklearmedizin·2007
8-other
PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial.
PMID 17693134·Lancet Oncol·2007
3-trial
Early response assessment using 3'-deoxy-3'-[18F]fluorothymidine-positron emission tomography in high-grade non-Hodgkin's lymphoma.
PMID 17575218·Clin Cancer Res·2007
8-other
Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction.
PMID 16966684·J Clin Oncol·2006
4-observational
Monitoring chemotherapy and radiotherapy of solid tumors.
PMID 16688451·Eur J Nucl Med Mol Imaging·2006
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 503 GRASSLANDS RD STE 200
VALHALLA, NY 10595 - Phone
- (914) 304-5250
Quick Facts
- NPI
- 1518014349
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 3
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile